Epoch 22: A Proxy for Market Health - the Initial Public Offering (IPO)
Macro, Backlog, Step-up, News Flow, Alternatives to IPO
Welcome to the 38 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 1,836 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.